|
05 Jun 2020 |
PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in Advanced Cervical Cancer
|
|
05 Jun 2020 |
Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
|
|
05 Jun 2020 |
Intravacc Partners With Wageningen Bioveterinary Research and Utrecht University to Develop an Intranasal COVID-19 Vaccine
|
|
05 Jun 2020 |
AstraZeneca takes next steps towards broad and equitable access to Oxford University’s COVID-19 vaccine
|
|
04 Jun 2020 |
INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea
|
|
03 Jun 2020 |
Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine
|
|
01 Jun 2020 |
Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19
|
|
01 Jun 2020 |
Coronavirus Vaccine Development Underway by Vault Pharma
|
|
31 May 2020 |
Treos Bio Reports Positive Final Results of Phase I/II Off-The-Shelf CRC Cancer Immunotherapy in 2020 ASCO Poster Presentation
|
|
31 May 2020 |
MimiVax Phase 2 study of SurVaxM in combination with pembrolizumab opens for recurrent glioblastoma patients
|
|
30 May 2020 |
Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
29 May 2020 |
Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola Vaccine Regimen
|
|
29 May 2020 |
Clinical Response and Translational Data from DeCidE1, a Phase 2 Study of DPX-Survivac Immunotherapy in Patients with Advanced Recurrent Ovarian Cancer
|
|
29 May 2020 |
Vaxxas Announces That Merck Exercises Option to Apply Novel Immune System Activation Platform for Vaccine Candidate
|
|
29 May 2020 |
GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations
|
|
29 May 2020 |
AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company
|
|
28 May 2020 |
ImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for ‘Operation Warp Speed’ to Develop Novel Adenovirus COVID-19 Vaccine
|
|
28 May 2020 |
Stallergenes Greer and Anergis Report Successful Preclinical Study Results With COP-virosomes as Second-generation Allergen Immunotherapy
|
|
26 May 2020 |
IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
|
|
26 May 2020 |
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
|
|
21 May 2020 |
IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies
|
|
21 May 2020 |
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
|
|
21 May 2020 |
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
|
|
20 May 2020 |
Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate
|
|
20 May 2020 |
INOVIO’s COVID-19 DNA vaccine INO-4800 demonstrates robust neutralizing antibody and T cell immune responses in preclinical models
|
